Login
908 Devices Inc. logo

908 Devices Inc.

908devices.com

What Do They Do?

Sells handheld chemical-analysis devices that identify unknown materials for government agencies, public-safety users and life-sciences customers.

How Do They Make Money?

Customers buy handheld devices and consumables, generally paying after shipment or delivery; support and warranty services are commonly paid in advance, at completion, or both.

revenue
SegmentShareRevenue
Device sales revenue
Sold outright

65%
FY2022: 61%
Recurring revenue
Mix

35%
FY2022: 34%
Contract revenue
0.2%
FY2022: 5.1%

Who Are Their Customers?

Government agencies and public-safety users are the main buyers, with life sciences customers also served. The company sells directly and through channel partners, including partners used when a U.S. government contract vehicle is required.

Do Revenues Turn Into Profits?

Yes. It kept 35 cents of every revenue dollar as net income in FY2025, but spent more cash than it brought in: free cash flow was −$24.6M.

Operating income, FY2025
−70% of revenue
▲ +31% (Loss) vs FY2024 (−$57.4M, −120%)
Net income, FY2025
35% of revenue
▲ Turned profitable vs FY2024 (−$72.2M, −151%)
Free cash flow, FY2025
−44% of revenue
▲ +20% (Loss) vs FY2024 (−$30.8M, −65%)

How Are They Changing?

Since the FY2025 annual report
Latest quarter: Q3 FY2026, the three months to Sep 30, 2026
Revenue
▲ +35%
vs $14M in Q3 FY2025
Net income
▲ +69% (Loss)
vs −$15M in Q3 FY2025
Device sales revenue share of revenue vs 65.1% in Q3 FY2025
  • Nov 10, 2026 Raises the lower end of its revenue outlook The range is now $68.5 million to $70.0 million, up from $68.0 million to $70.0 million.
  • May 4, 2026 Acquires NIRLAB, adding near-infrared spectroscopy products NIRLAB develops near-infrared spectroscopy solutions for instant material identification.

Growing. Revenue grew 33% in 4 years, from $42.2M in FY2021 to $56.2M in FY2025, about 7% a year.

Desktop portfolio sale The older report described handheld and desktop Mass Spec devices for life-sciences and bioprocessing uses. The latest report centers on handheld devices; the company says it sold its Desktop Portfolio.

Optical spectroscopy added The older report presented Mass Spec as the company's analytical platform. The latest report adds optical spectroscopy, including technologies obtained with RedWave.

Revenue over time
Device sales revenue Recurring revenue Contract revenue
$100M$50M$0

Who Do They Compete With?

Competes with Agilent, Bruker, Danaher, Inficon, Teledyne, Rigaku, and Thermo Fisher Scientific

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support